K+ channel blockade in the prevention of ventricular fibrillation in dogs with acute ischemia and enhanced sympathetic activity

Emilio Vanoli, Stephen S. Hull, Philip B. Adamson, Robert D. Foreman, Peter J. Schwartz

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

The value of K+ channel blockade in preventing lethal arrhythmias, and specifically those triggered by acute myocardial ischemia and sympathetic hyperactivity, remains unproven. To address this issue, we tested the antifibrillatory effect of d-sotalol, an Ikr blocker, d, l-sotalol, its racemic compound which blocks Ikr, and β-adrenoreceptors, and propranolol. Ten dogs with a healed anterior myocardial infarction (MI) had ventricular fibrillation (VF) during a 2-min occlusion of the circumflex coronary artery performed toward the end of a submaximal exercise stress test. In successive trials in the same animals, d-sotalol (three injections of 8 mg/kg, one every 12 h), d, l-sotalol (8 mg/kg), and propranolol (1 mg/kg) were tested. All three interventions significantly reduced heart rate (HR) response to exercise, but only d, l-sotalol and propranolol also blunted the reflex HR increase during acute myocardial ischemia. With d-sotalol, HR at 30 s of coronary occlusion was similar (253 ± 28 beats/min) to that observed in the control tests (259 ± 35 beats/min). d-Sotalol prevented recurrence of VF in only 1 of 10 dogs tested. One dog was lost to the continuation of the study after occurrence of VF with rf-sotalol. Six of 9 dogs (67%) tested with d, l-sotalol and 5 (56%) of the same 9 dogs tested with propranolol were protected from VF. d-Sotalol does not reduce risk of VF during acute myocardial ischemia associated with sympathetic hyperactivity, and lethal events can be prevented by antiadrenergic interventions.

Original languageEnglish
Pages (from-to)847-854
Number of pages8
JournalJournal of Cardiovascular Pharmacology
Volume26
Issue number6
Publication statusPublished - 1995

Fingerprint

Sotalol
Ventricular Fibrillation
Ischemia
Dogs
Propranolol
Myocardial Ischemia
Heart Rate
Exercise Test
Adrenergic Antagonists
Coronary Occlusion
Reflex
Cardiac Arrhythmias
Coronary Vessels
Myocardial Infarction

Keywords

  • Antiarrhythmic drugs
  • Sudden cardiac death
  • Ventricular repolarization

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pharmacology

Cite this

K+ channel blockade in the prevention of ventricular fibrillation in dogs with acute ischemia and enhanced sympathetic activity. / Vanoli, Emilio; Hull, Stephen S.; Adamson, Philip B.; Foreman, Robert D.; Schwartz, Peter J.

In: Journal of Cardiovascular Pharmacology, Vol. 26, No. 6, 1995, p. 847-854.

Research output: Contribution to journalArticle

@article{035ad913d1494c87ad9525192243ef9b,
title = "K+ channel blockade in the prevention of ventricular fibrillation in dogs with acute ischemia and enhanced sympathetic activity",
abstract = "The value of K+ channel blockade in preventing lethal arrhythmias, and specifically those triggered by acute myocardial ischemia and sympathetic hyperactivity, remains unproven. To address this issue, we tested the antifibrillatory effect of d-sotalol, an Ikr blocker, d, l-sotalol, its racemic compound which blocks Ikr, and β-adrenoreceptors, and propranolol. Ten dogs with a healed anterior myocardial infarction (MI) had ventricular fibrillation (VF) during a 2-min occlusion of the circumflex coronary artery performed toward the end of a submaximal exercise stress test. In successive trials in the same animals, d-sotalol (three injections of 8 mg/kg, one every 12 h), d, l-sotalol (8 mg/kg), and propranolol (1 mg/kg) were tested. All three interventions significantly reduced heart rate (HR) response to exercise, but only d, l-sotalol and propranolol also blunted the reflex HR increase during acute myocardial ischemia. With d-sotalol, HR at 30 s of coronary occlusion was similar (253 ± 28 beats/min) to that observed in the control tests (259 ± 35 beats/min). d-Sotalol prevented recurrence of VF in only 1 of 10 dogs tested. One dog was lost to the continuation of the study after occurrence of VF with rf-sotalol. Six of 9 dogs (67{\%}) tested with d, l-sotalol and 5 (56{\%}) of the same 9 dogs tested with propranolol were protected from VF. d-Sotalol does not reduce risk of VF during acute myocardial ischemia associated with sympathetic hyperactivity, and lethal events can be prevented by antiadrenergic interventions.",
keywords = "Antiarrhythmic drugs, Sudden cardiac death, Ventricular repolarization",
author = "Emilio Vanoli and Hull, {Stephen S.} and Adamson, {Philip B.} and Foreman, {Robert D.} and Schwartz, {Peter J.}",
year = "1995",
language = "English",
volume = "26",
pages = "847--854",
journal = "Journal of Cardiovascular Pharmacology",
issn = "0160-2446",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - K+ channel blockade in the prevention of ventricular fibrillation in dogs with acute ischemia and enhanced sympathetic activity

AU - Vanoli, Emilio

AU - Hull, Stephen S.

AU - Adamson, Philip B.

AU - Foreman, Robert D.

AU - Schwartz, Peter J.

PY - 1995

Y1 - 1995

N2 - The value of K+ channel blockade in preventing lethal arrhythmias, and specifically those triggered by acute myocardial ischemia and sympathetic hyperactivity, remains unproven. To address this issue, we tested the antifibrillatory effect of d-sotalol, an Ikr blocker, d, l-sotalol, its racemic compound which blocks Ikr, and β-adrenoreceptors, and propranolol. Ten dogs with a healed anterior myocardial infarction (MI) had ventricular fibrillation (VF) during a 2-min occlusion of the circumflex coronary artery performed toward the end of a submaximal exercise stress test. In successive trials in the same animals, d-sotalol (three injections of 8 mg/kg, one every 12 h), d, l-sotalol (8 mg/kg), and propranolol (1 mg/kg) were tested. All three interventions significantly reduced heart rate (HR) response to exercise, but only d, l-sotalol and propranolol also blunted the reflex HR increase during acute myocardial ischemia. With d-sotalol, HR at 30 s of coronary occlusion was similar (253 ± 28 beats/min) to that observed in the control tests (259 ± 35 beats/min). d-Sotalol prevented recurrence of VF in only 1 of 10 dogs tested. One dog was lost to the continuation of the study after occurrence of VF with rf-sotalol. Six of 9 dogs (67%) tested with d, l-sotalol and 5 (56%) of the same 9 dogs tested with propranolol were protected from VF. d-Sotalol does not reduce risk of VF during acute myocardial ischemia associated with sympathetic hyperactivity, and lethal events can be prevented by antiadrenergic interventions.

AB - The value of K+ channel blockade in preventing lethal arrhythmias, and specifically those triggered by acute myocardial ischemia and sympathetic hyperactivity, remains unproven. To address this issue, we tested the antifibrillatory effect of d-sotalol, an Ikr blocker, d, l-sotalol, its racemic compound which blocks Ikr, and β-adrenoreceptors, and propranolol. Ten dogs with a healed anterior myocardial infarction (MI) had ventricular fibrillation (VF) during a 2-min occlusion of the circumflex coronary artery performed toward the end of a submaximal exercise stress test. In successive trials in the same animals, d-sotalol (three injections of 8 mg/kg, one every 12 h), d, l-sotalol (8 mg/kg), and propranolol (1 mg/kg) were tested. All three interventions significantly reduced heart rate (HR) response to exercise, but only d, l-sotalol and propranolol also blunted the reflex HR increase during acute myocardial ischemia. With d-sotalol, HR at 30 s of coronary occlusion was similar (253 ± 28 beats/min) to that observed in the control tests (259 ± 35 beats/min). d-Sotalol prevented recurrence of VF in only 1 of 10 dogs tested. One dog was lost to the continuation of the study after occurrence of VF with rf-sotalol. Six of 9 dogs (67%) tested with d, l-sotalol and 5 (56%) of the same 9 dogs tested with propranolol were protected from VF. d-Sotalol does not reduce risk of VF during acute myocardial ischemia associated with sympathetic hyperactivity, and lethal events can be prevented by antiadrenergic interventions.

KW - Antiarrhythmic drugs

KW - Sudden cardiac death

KW - Ventricular repolarization

UR - http://www.scopus.com/inward/record.url?scp=0028883474&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028883474&partnerID=8YFLogxK

M3 - Article

C2 - 8606519

AN - SCOPUS:0028883474

VL - 26

SP - 847

EP - 854

JO - Journal of Cardiovascular Pharmacology

JF - Journal of Cardiovascular Pharmacology

SN - 0160-2446

IS - 6

ER -